echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Announcement of the State Drug Administration on Protected Varieties of Traditional Chinese Medicines (Extended Protection Period No. 6) (No. 146 of 2020)

    Announcement of the State Drug Administration on Protected Varieties of Traditional Chinese Medicines (Extended Protection Period No. 6) (No. 146 of 2020)

    • Last Update: 2021-07-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to Article 16 of the Regulations on the Protection of Traditional Chinese Medicines and related regulations, after review by members organized by the National Traditional Chinese Medicines Protection Review Committee, the State Drug Administration approved:

    The protected varieties of ginkgo ketone ester dripping pills produced by Zhejiang Jiuxu Pharmaceutical Co.


    Hereby announce



    State Food and Drug Administration

    December 28, 2020



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.